Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-011611

Chief Operating Officer sold 63,700 shares at $2.55 ($162,435)

From the SEC's structured data for this filing

Trades in this filing

Dagnon Terry · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-12 Sale : show line 1 in the form −63,700 $2.55 $162,435 1,143,757 D
Open-market sales · 63,700 sh · avg $2.55 · $162,435
Loading xslF345X03/doc4.xml…